Related Experiment Video

Updated: May 16, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Computational modeling and simulation of the Bcl-2 family: paving the way for rational drug design

J L Rosas-Trigueros1, I Ilizaliturri-Flores, C G Benítez-Cardoza

  • 1SEPI de la ESCOM del Instituto Politécnico Nacional, México D.F. 07738, México.

Current Medicinal Chemistry
|November 16, 2012
PubMed

Insights

Computational studies of Bcl-2 family proteins are crucial for understanding their roles beyond apoptosis and for developing new drugs. This review highlights computational methods like molecular dynamics and docking for structural insights.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Biology

Background:

  • Bcl-2 family proteins regulate mitochondrial integrity and apoptosis.
  • Emerging evidence links these proteins to autophagy, ER signaling, and synaptic activity.
  • Structural information is key for developing targeted therapies.

Purpose of the Study:

  • To review computational studies on Bcl-2 family proteins.
  • To evaluate diverse computational strategies for structural analysis.
  • To demonstrate the importance of structural details in drug design.

Main Methods:

  • Molecular Dynamics (MD) simulations
  • Molecular docking
  • Rational drug design

Main Results:

  • Computational methods provide valuable structural insights into Bcl-2 proteins.
  • Analysis of ligand and protein structures is critical.
  • These insights are directly relevant to drug discovery and development.

Conclusions:

  • Computational approaches are essential for advancing the study of Bcl-2 family proteins.
  • Understanding structural details through computation aids in designing effective therapeutics.
  • This review underscores the utility of computational biology in drug development.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...